Researchers on Wednesday reported two promising new approaches to counteract malaria’s growing resistance to medication — one involving a new class of drugs.

Switzerland-based Novartis released results of what it called a next-generation treatment. A study of its experimental drug in 12 African countries found it works well against the mosquito-borne parasite that causes malaria and seems to block spread.

The drug, called GanLum, is not yet licensed and more than a year away from being available.

  • StinkyFingerItchyBum@lemmy.ca
    link
    fedilink
    English
    arrow-up
    3
    ·
    edit-2
    1 day ago

    Editorialized headline get a downvote though I like the post.

    “2 new malaria treatments show promise as drug resistance grows”

    Vs

    “2 new malaria treatments announced…”

    These drugs are going through trials and approvals and show promise. They may ultimately fail and never seenlight of day.